Research Analysts at Deutsche Bank Kept the Same their Hold rating for Tableau Software (DATA). The Target is Set to $70; Cyclacel Pharmaceuticals (CYCC) Sellers Increased By 29.61% Their Shorts

August 4, 2017 - By Maria Brooks

Cyclacel Pharmaceuticals Incorporated (NASDAQ:CYCC) had an increase of 29.61% in short interest. CYCC’s SI was 350,600 shares in August as released by FINRA. Its up 29.61% from 270,500 shares previously. With 42,200 avg volume, 8 days are for Cyclacel Pharmaceuticals Incorporated (NASDAQ:CYCC)’s short sellers to cover CYCC’s short positions. The SI to Cyclacel Pharmaceuticals Incorporated’s float is 13.48%. It closed at $1.67 lastly. It is down 10.62% since August 4, 2016 and is uptrending. It has underperformed by 6.08% the S&P500.

Among 38 analysts covering Tableau Software (NYSE:DATA), 16 have Buy rating, 3 Sell and 19 Hold. Therefore 42% are positive. Tableau Software has $145 highest and $24.0 lowest target. $72.90’s average target is 4.44% above currents $69.8 stock price. Tableau Software had 106 analyst reports since July 24, 2015 according to SRatingsIntel. On Friday, May 6 the stock rating was downgraded by Mitsubishi UFJ to “Underweight”. The company was maintained on Friday, May 26 by Jefferies. As per Tuesday, August 1, the company rating was maintained by Drexel Hamilton. Robert W. Baird maintained the shares of DATA in report on Wednesday, February 24 with “Outperform” rating. As per Friday, February 3, the company rating was maintained by BMO Capital Markets. Deutsche Bank maintained it with “Hold” rating and $70 target in Thursday, August 3 report. The stock of Tableau Software Inc (NYSE:DATA) has “Hold” rating given on Tuesday, January 12 by Brean Capital. The firm has “Buy” rating given on Friday, February 5 by UBS. The stock of Tableau Software Inc (NYSE:DATA) earned “Outperform” rating by Robert W. Baird on Tuesday, August 23. BMO Capital Markets maintained the stock with “Outperform” rating in Thursday, May 4 report.

Investors sentiment increased to 1.05 in 2016 Q4. Its up 0.10, from 0.95 in 2016Q3. It increased, as 32 investors sold Tableau Software Inc shares while 59 reduced holdings. 31 funds opened positions while 65 raised stakes. 54.34 million shares or 1.03% more from 53.78 million shares in 2016Q3 were reported. Altimeter Cap Mngmt L P holds 2.59 million shares or 5.61% of its portfolio. Rhumbline Advisers invested 0.01% of its portfolio in Tableau Software Inc (NYSE:DATA). 797,414 are owned by Millennium Management Limited Liability Company. Dupont Capital Mngmt Corporation holds 11,091 shares or 0.01% of its portfolio. Ironwood Management Llc reported 17,049 shares. Raymond James & Associates stated it has 21,918 shares. Patten Group Incorporated has invested 0.01% in Tableau Software Inc (NYSE:DATA). Eagle Asset Mngmt has invested 0.07% in Tableau Software Inc (NYSE:DATA). Winfield Associate, a Ohio-based fund reported 2,265 shares. Bnp Paribas Arbitrage, a New York-based fund reported 971 shares. Architects holds 0% or 57 shares in its portfolio. State Of Wisconsin Invest Board holds 30,082 shares or 0.01% of its portfolio. Morgan Stanley holds 0% or 251,525 shares in its portfolio. Northern Trust stated it has 0% in Tableau Software Inc (NYSE:DATA). Pine River Cap Management L P accumulated 0.68% or 370,266 shares.

The stock increased 9.03% or $5.78 during the last trading session, reaching $69.8. About shares traded. Tableau Software Inc (NYSE:DATA) has risen 25.71% since August 4, 2016 and is uptrending. It has outperformed by 9.01% the S&P500.

Tableau Software, Inc. offers software products. The company has market cap of $5.44 billion. The Company’s products are used by people of diverse skill levels across all kinds of organizations. It currently has negative earnings. The Company’s products are used by people of skill levels across all kinds of organizations.